ATE473448T1 - Verfahren zur diagnose von herz-kreislauf- krankheiten - Google Patents

Verfahren zur diagnose von herz-kreislauf- krankheiten

Info

Publication number
ATE473448T1
ATE473448T1 AT07718389T AT07718389T ATE473448T1 AT E473448 T1 ATE473448 T1 AT E473448T1 AT 07718389 T AT07718389 T AT 07718389T AT 07718389 T AT07718389 T AT 07718389T AT E473448 T1 ATE473448 T1 AT E473448T1
Authority
AT
Austria
Prior art keywords
amount
precursor
fragments
sample
cardiovascular diseases
Prior art date
Application number
AT07718389T
Other languages
English (en)
Inventor
Hendrik Ankersmit
Original Assignee
Univ Wien Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wien Med filed Critical Univ Wien Med
Application granted granted Critical
Publication of ATE473448T1 publication Critical patent/ATE473448T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4742Keratin; Cytokeratin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/545IL-1
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07718389T 2006-04-24 2007-04-16 Verfahren zur diagnose von herz-kreislauf- krankheiten ATE473448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT6942006 2006-04-24
PCT/AT2007/000173 WO2007121495A2 (en) 2006-04-24 2007-04-16 Method for diagnosing cardiovascular diseases

Publications (1)

Publication Number Publication Date
ATE473448T1 true ATE473448T1 (de) 2010-07-15

Family

ID=38171226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07718389T ATE473448T1 (de) 2006-04-24 2007-04-16 Verfahren zur diagnose von herz-kreislauf- krankheiten

Country Status (7)

Country Link
US (1) US8129135B2 (de)
EP (1) EP2010921B1 (de)
JP (1) JP2009534672A (de)
AT (1) ATE473448T1 (de)
DE (1) DE602007007595D1 (de)
ES (1) ES2346483T3 (de)
WO (1) WO2007121495A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2937339B1 (fr) 2008-10-21 2013-02-15 Univ Bourgogne Procede de detection de la maladie atheromateuse.
GB0911569D0 (en) 2009-07-03 2009-08-12 Ulive Entpr Ltd Method for the detection of organ or tissue injury
CN102792161B (zh) * 2009-08-28 2014-11-12 阿斯图特医药公司 肾损伤和肾衰竭的诊断及预后的方法及组合物
CN110089997A (zh) * 2018-01-31 2019-08-06 上海交通大学 基于体表自发荧光左右对称性和强度判断心肌梗死和心力衰竭及愈后程度的方法及其应用
CN110095440A (zh) * 2018-01-31 2019-08-06 上海交通大学 基于体表自发荧光左右对称性和强度判断脑卒中发生及愈后程度的方法及其应用
CN110089999A (zh) * 2018-01-31 2019-08-06 上海交通大学 基于角蛋白片段和角蛋白水平及左右对称性的检测判断心脑血管疾病的应用和方法
CN110090001A (zh) * 2018-01-31 2019-08-06 上海交通大学 自发荧光在判断心脑血管病中的应用
CN110132906A (zh) * 2018-02-02 2019-08-16 上海交通大学 基于指甲自发荧光左右对称性和强度判断心肌梗死和心力衰竭及愈后程度的方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321351T3 (es) * 1997-09-30 2009-06-04 Peviva Ab Compuesto relacionados con apoptosis y su uso.
JP3806694B2 (ja) * 2001-05-04 2006-08-09 バイオサイト インコーポレイテッド 急性冠状動脈症候群の診断マーカーおよびその使用方法
DE112007003185A5 (de) * 2006-10-26 2009-10-01 Brahms Aktiengesellschaft Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II

Also Published As

Publication number Publication date
US8129135B2 (en) 2012-03-06
EP2010921A2 (de) 2009-01-07
US20090098104A1 (en) 2009-04-16
WO2007121495A2 (en) 2007-11-01
EP2010921B1 (de) 2010-07-07
JP2009534672A (ja) 2009-09-24
WO2007121495A3 (en) 2008-02-21
ES2346483T3 (es) 2010-10-15
DE602007007595D1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
DE602007007595D1 (en) Ten
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
WO2005048823A3 (en) Modeling of systemic inflammatory response to infection
ATE452343T1 (de) Verbesserte vitamin-d-messung
EP2402438A3 (de) Proteaseabtastverfahren und damit identifizierte Protease
WO2007062090A8 (en) Methods and compositions related to b cell assays
DE602006015281D1 (de) Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind
WO2010061283A8 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
ATE524561T1 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
ATE376672T1 (de) Verfahren zur diagnose von multipler sklerose
ATE508364T1 (de) Diagnoseverfahren für präeklampsie
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
DE602005023009D1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
DE602006017058D1 (de) Verfahren zur stratifizierung von herzinsuffizienz
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
EP2270034A3 (de) Mittel und Methoden zur Diagnose von Stress
HRP20191862T1 (hr) Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina
WO2005103713A3 (en) Methods, compositions and compound assays for inhibiting amyloid-beta protein production
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE355389T1 (de) Verfahren zur diagnose von schizophrenie
DE602006020850D1 (de) Biomarker zur diagnose einer herzerkrankung sowie verwendung davon
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
WO2006002930A3 (en) FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2010921

Country of ref document: EP